Tandem Diabetes Care Inc
F:TD5A
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Tandem Diabetes Care Inc
F:TD5A
|
US |
|
B
|
Bank of Nova Scotia
XBER:BKN
|
CA |
|
Research Solutions Inc
NASDAQ:RSSS
|
US |
|
Liontrust Asset Management PLC
LSE:LIO
|
UK |
|
F
|
Frasers Property Thailand Industrial Freehold & Leasehold REIT
SET:FTREIT
|
TH |
|
H
|
Home Product Center PCL
SET:HMPRO
|
TH |
|
H
|
Hyatt Hotels Corp
F:1HTA
|
US |
|
Hoya Corp
OTC:HOCPF
|
JP |
Wall St Price Targets
TD5A Price Targets Summary
Tandem Diabetes Care Inc
According to Wall Street analysts, the average 1-year price target for TD5A is 17.35 EUR with a low forecast of 10.61 EUR and a high forecast of 30.63 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TD5A's stock price target?
Price Target
17.35
EUR
According to Wall Street analysts, the average 1-year price target for TD5A is 17.35 EUR with a low forecast of 10.61 EUR and a high forecast of 30.63 EUR.
What is the Revenue forecast for Tandem Diabetes Care Inc?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Revenue has been 59%. The projected CAGR for the next 8 years is 8%.
What is the Gross Profit forecast for Tandem Diabetes Care Inc?
Projected CAGR
9%
The compound annual growth rate for Gross Profit over the next 8 years is 9%.
